Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biomedical Innovation Departament, |
RCV001352722 | SCV001547399 | pathogenic | Epidermolysis bullosa simplex | 2015-09-22 | criteria provided, single submitter | research | |
Invitae | RCV000056599 | SCV003440539 | pathogenic | not provided | 2022-08-10 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 165 of the KRT5 protein (p.Arg165Ser). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KRT5 protein function. ClinVar contains an entry for this variant (Variation ID: 66246). This missense change has been observed in individual(s) with autosomal dominant epidermolysis bullosa simplex (PMID: 18384561). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). |
Epithelial Biology; Institute of Medical Biology, |
RCV000056599 | SCV000087712 | not provided | not provided | no assertion provided | not provided |